Bonzun

Name

Bonzun

Legal name

Bonzun Health Information AB

Website

https://bonzun.com

Company type

Public

Founded year

2014

Operating status

Ipo

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Femtech / Mobile Health Applications

NAICS

Software Publishers (5132), Medical Equipment and Supplies Manufacturing (3391)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Meditation Apps, Digital Courses & Online Communities (HSADAJAH)

akta.pro secondary industry

Women’s Health & Reproductive Specialty Pharmaceuticals (HLAIACAN)

Keywords

• Fertility mobile app
• IVF companion app
• Pregnancy health app
• Corporate wellness program
• Virtual midwife app

Headquarters

HQ city

Stockholm

HQ country

Sweden

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Bonzun IVF App Subscriptions: Bonzun IVF is accessible via clinic codes provided by partner IVF clinics, direct subscription purchases through the Apple App Store or Google Play Store (monthly or one-time unlock), or unlimited use subscriptions. This is the primary revenue stream for the consumer fertility app.
2. Bonzun Evolve Enterprise Licensing: Bonzun evolve is sold to companies and organizations as a corporate wellness program for employee stress reduction. This B2B enterprise license model provides the 8-session ACT-based program to employees.
3. Freemium / Free Consumer App (China): The Kou Dai Yun Yu (virtual midwife) pregnancy app is provided free to users in China. This creates brand awareness and user base, potentially enabling future monetization or data insights.
4. IVF Clinic Partnership Revenue: Bonzun generates revenue through partnerships with IVF clinics that distribute the app to patients. Partner clinics benefit from increased success rates and patient retention, while Bonzun gains distribution through clinical channels.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

Core offering

Bonzun develops and sells mobile health applications for pregnancy, fertility treatment, and corporate stress management. Its core products are Bonzun IVF (a personalized IVF companion app with 220+ million journey variations, CE-marked as a medical device), Bonzun Evolve (an 8-session ACT-based corporate wellness program for workplace stress), and Kou Dai Yun Yu (a free virtual midwife app for pregnant women in China).

Product overview

Bonzun is a femtech company offering a portfolio of digital health applications. The product line consists of three main offerings: Bonzun IVF (a personalized IVF companion app), Bonzun Evolve (an evidence-based stress management program for employees), and Kou Dai Yun Yu (a virtual midwife app for pregnant women in China). The company was founded in 2014 and launched on Nasdaq First North Growth Market in 2021.

Differentiator

Problem solved

Functional benefit

Brands

• Bonzun IVF: World's first personalized and complete IVF app that guides users through their unique IVF journey. Smart tools and emotional support to increase chances of succeeding with ART treatments (IVF, ICSI, FET). CE-marked medical device with medically reviewed content.
• Bonzun Evolve
• Kou Dai Yun Yu (口袋孕育)

Products and services

• Bonzun IVF The world's first personalized and complete IVF companion app that guides users through their unique IVF, ICSI, or Frozen Embryo Transfer (FET) journey. Provides step-by-step treatment guidance, medication tracking with reminders for 20+ IVF medications, test-result upload with explanation, and emotional-support content. CE-marked as a medical device under European standards and developed with medically reviewed content. Available globally in 95+ countries via App Store and Google Play, and distributed through partner IVF clinics using clinic access codes.
• Bonzun Evolve Interactive evidence-based corporate wellness program that helps companies and their employees develop self-leadership and coping mechanisms for stressful work situations. Built on Acceptance and Commitment Therapy (ACT), delivered as an 8-session structured program designed to stimulate behavioural change and reduce workplace stress. Sold to corporate clients for use by their workforce.
• Kou Dai Yun Yu (Virtual Midwife) Virtual midwife mobile app for pregnant women in China. Helps users understand when to seek a doctor versus safely stay home, explains the meaning of test results, and monitors pregnancy progress over time. Backed by WHO and UNICEF, supported by Chinese Maternal & Child Health Association (MCHAC), and available free to users across 32 Chinese app stores.

Quantifiable outcome

• 220,000 patient journeys tracked in Bonzun IVF
• +3 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature6 records

Partnerships

Ten partnerships are on record, tiered core, flagship and minor.

• Merck Fertility Technologies (Sweden)coreTechnology or IntegrationBonzun IVF was developed in close cooperation with Merck Fertility Technologies in Sweden. This partnership provided clinical and fertility expertise for the development of the world's first personalized IVF app, with Merck contributing to the medical content validation and treatment protocol design.
• Merck Fertility Technologies (Sweden)coreTechnology or IntegrationMerck Fertility Technologies is listed as a Medical Content Review Partner for Bonzun IVF, ensuring all medical content meets regulatory and clinical standards. Their involvement ensures the app's medical information is accurate and reliable for patients.
• UNICEFflagshipOthersBonzun's virtual midwife pregnancy app has been backed by UNICEF. This endorsement provides significant credibility and support for Bonzun's mission to improve maternal and child health outcomes globally.
• World Health Organization (WHO)flagshipOthersBonzun has been backed by the World Health Organization. WHO recognition provides Bonzun with global health credibility and supports its mission of improving maternal and child health through digital health technology.
• China CDC - National Center for Women's & Children's HealthcoreStrategic or Co-development PartnerChina CDC's National Center for Women's & Children's Health is a key institutional partner, providing expertise and credibility for Bonzun's pregnancy app in China. The partnership ensures the app aligns with Chinese national health standards.
• Chinese Maternal & Child Health Association (MCHAC)coreStrategic or Co-development PartnerMCHAC encompasses approximately 3,500 hospitals across China and serves as a major institutional partner for Bonzun's pregnancy app. This partnership provides extensive hospital network distribution and clinical credibility for the virtual midwife app.
• Karolinska InstituteminorStrategic or Co-development PartnerKarolinska Institute in Sweden, one of the world's leading medical universities, is listed as an institutional backer of Bonzun, providing academic credibility to the company's evidence-based approach.
• Fudan University School of Public HealthminorStrategic or Co-development PartnerFudan University School of Public Health in Shanghai is a backing institution for Bonzun, contributing academic research expertise to the company's evidence base for the pregnancy app.
• Guangzhou Women & Children's Medical CenterminorStrategic or Co-development PartnerGuangzhou Women & Children's Medical Center is listed as a backing institution for Bonzun, providing clinical expertise from a major women's and children's hospital in China.
• IVF Clinics WorldwidecoreChannel Partner/ Reseller/ DistributorBonzun partners with IVF and fertility clinics worldwide through a partnership program. Partner clinics distribute Bonzun IVF to patients via access codes, benefiting from increased success rates, improved patient retention, and enhanced clinic efficiency. Clinics provide feedback that helps improve the app.

Scale indicators8 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Clue: Clue is a Berlin-based direct competitor offering a cycle/fertility tracking app with strong European user base and CE-marked health data practices; mirrors Bonzun's European roots and reproductive health positioning, especially for users tracking natural conception and cycle awareness.
• Headspace: Headspace is a global meditation and mental wellness app with a substantial Headspace for Work enterprise product; directly comparable to Bonzun Evolve on both the consumer subscription side and B2B corporate mindfulness channel, and overlaps with Bonzun IVF's emotional support feature.
• Glow: Glow offers fertility, pregnancy, and women's health tracking apps including Glow Baby and Glow Nurture; directly comparable mobile consumer femtech platform targeting similar user journeys around conception, pregnancy, and postpartum, overlapping heavily with Bonzun IVF and Kou Dai Yun Yu.
• Flo Health: Flo operates the leading consumer women's health and period/fertility tracking app with over 60M monthly active users globally; directly comparable as a subscription-based femtech mobile app targeting women for cycle, pregnancy, and reproductive health tracking.
• Calm: Calm is the leading consumer meditation, mindfulness, and stress management app with B2B Calm Business offering; directly comparable to Bonzun Evolve as both deliver subscription-based mindfulness/stress management content to consumers and through corporate employer channels.
• Natural Cycles: Natural Cycles is a CE-marked, FDA-cleared fertility app with subscription model targeting women planning or avoiding pregnancy; directly comparable as a regulated, subscription-driven reproductive health mobile product competing for the same patient demographic as Bonzun IVF.

Broad incumbents

• Maven Clinic: Maven Clinic is a virtual care platform for women's and family health covering fertility, pregnancy, postpartum, and pediatrics via telehealth providers; overlapping with Bonzun IVF and Kou Dai Yun Yu on the fertility/pregnancy care continuum but offered by a much larger, well-funded incumbent with clinician services.
• Kindbody: Kindbody operates fertility clinics and employer fertility benefits at scale; comparable to Bonzun's IVF clinic partnership channel because both reach IVF patients through clinics/employers, though Kindbody owns the clinic layer whereas Bonzun serves as a patient-complementary digital tool.
• Progyny: Progyny is a US fertility benefits management company serving employers and patients; comparable to Bonzun's IVF clinic channel because both deliver digital fertility support to patients undergoing ART, though Progyny is a publicly traded benefits administrator rather than a consumer app publisher.
• Ovia Health (Labcorp): Ovia Health is a women's health digital platform covering fertility, pregnancy, and parenting with employer benefits integration; overlaps with Bonzun on pregnancy/IVF mobile app functionality while serving a much larger employer benefits market through its Labcorp parent.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/bonzunapp
• LinkedInlinkedin.com/company/bonzun

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bonzun